However, subsequent studies demonstrated that although CD133 is a useful prognostic indicator for assessing the risk of colon cancer metastasis, recurrence, and progression, it seems unlikely to contribute directly to the metastasis of colon cancer [12–14]. Here, PROM1 is linked to colonic neoplasm.